NO20091297L - Stabile farmakologisk aktive preparater innbefattende vitamin-D-holdige forbindelser og kortikosteroidforbindelser med lav PH-forlikelighet - Google Patents
Stabile farmakologisk aktive preparater innbefattende vitamin-D-holdige forbindelser og kortikosteroidforbindelser med lav PH-forlikelighetInfo
- Publication number
- NO20091297L NO20091297L NO20091297A NO20091297A NO20091297L NO 20091297 L NO20091297 L NO 20091297L NO 20091297 A NO20091297 A NO 20091297A NO 20091297 A NO20091297 A NO 20091297A NO 20091297 L NO20091297 L NO 20091297L
- Authority
- NO
- Norway
- Prior art keywords
- compounds
- compatibility
- low
- corticosteroid
- pharmacologically active
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 238000002360 preparation method Methods 0.000 title abstract 4
- 229930003316 Vitamin D Natural products 0.000 title abstract 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 title abstract 2
- 239000003246 corticosteroid Substances 0.000 title abstract 2
- 235000019166 vitamin D Nutrition 0.000 title abstract 2
- 239000011710 vitamin D Substances 0.000 title abstract 2
- 150000003710 vitamin D derivatives Chemical class 0.000 title abstract 2
- 229940046008 vitamin d Drugs 0.000 title abstract 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 abstract 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 229930182478 glucoside Natural products 0.000 abstract 1
- 150000008131 glucosides Chemical class 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- -1 sorbitan fatty acid esters Chemical class 0.000 abstract 1
- 229950011392 sorbitan stearate Drugs 0.000 abstract 1
- 150000003626 triacylglycerols Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84116406P | 2006-08-29 | 2006-08-29 | |
| PCT/US2007/019164 WO2008027532A2 (en) | 2006-08-29 | 2007-08-29 | Pharmaceutical compositions including vitamin d and corticosteroid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20091297L true NO20091297L (no) | 2009-03-27 |
Family
ID=38880988
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20091297A NO20091297L (no) | 2006-08-29 | 2009-03-27 | Stabile farmakologisk aktive preparater innbefattende vitamin-D-holdige forbindelser og kortikosteroidforbindelser med lav PH-forlikelighet |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20080064669A1 (pt) |
| EP (1) | EP2056791A2 (pt) |
| JP (1) | JP2010502624A (pt) |
| KR (2) | KR20110113664A (pt) |
| CN (1) | CN101505725A (pt) |
| BR (1) | BRPI0715636A2 (pt) |
| CA (1) | CA2670425A1 (pt) |
| IL (1) | IL197107A0 (pt) |
| MX (1) | MX2009002337A (pt) |
| NO (1) | NO20091297L (pt) |
| RU (1) | RU2452488C2 (pt) |
| WO (1) | WO2008027532A2 (pt) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8404667B2 (en) * | 2006-12-29 | 2013-03-26 | Wisconsin Alumni Research Foundation | Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by 19-Nor vitamin D analog |
| US20060176966A1 (en) * | 2005-02-07 | 2006-08-10 | Stewart Kenneth A | Variable cyclic prefix in mixed-mode wireless communication systems |
| CA2761039A1 (en) * | 2009-05-07 | 2010-11-11 | Tolmar, Inc. | Pharmaceutical composition including a corticosteroid and a vitamin d analog having improved stability |
| US20110053898A1 (en) * | 2009-08-26 | 2011-03-03 | Glenmark Generics Ltd | Topical composition comprising vitamin d analogue and corticosteroids |
| US8518917B2 (en) * | 2009-10-02 | 2013-08-27 | Wisconsin Alumni Research Foundation | 2-methylene-19-nor-vitamin D analogs and their uses |
| JP5712010B2 (ja) * | 2010-03-24 | 2015-05-07 | 第一三共ヘルスケア株式会社 | ビタミンｄ類が安定化された化粧用又は医薬用外用組成物 |
| CN103442700B (zh) * | 2011-03-24 | 2016-04-06 | 利奥制药有限公司 | 含有脂质纳米颗粒和皮质类固醇或维生素d衍生物的组合物 |
| AU2012251135A1 (en) * | 2011-05-02 | 2013-11-07 | Lipidor Ab | Treatment of psoriasis |
| EP2736892A4 (en) * | 2011-07-29 | 2015-03-18 | Beijing Betta Pharmaceuticals Co Ltd | STABLE POLYMORPHIC FORMS OF A CONNECTION AS HYPOXIEMIMETICS AND USES THEREOF |
| US20170072321A1 (en) * | 2013-05-22 | 2017-03-16 | David S. Thompson | Highly interactive fantasy sports interleaver |
| WO2017118885A1 (en) * | 2016-01-04 | 2017-07-13 | Gland Pharma Limited | Stable pharmacuetical compositions of calcitriol |
| EP3542788A1 (en) * | 2018-03-19 | 2019-09-25 | MC2 Therapeutics Limited | Topical composition comprising calcipotriol and betamethasone dipropionate |
| CN108815174A (zh) * | 2018-05-25 | 2018-11-16 | 昆山普瑞凯纳米技术有限公司 | 一种改良型脂溶性组合物及其制备方法 |
| WO2020044223A1 (en) * | 2018-08-28 | 2020-03-05 | Glenmark Pharmaceuticals Limited | Container system and pharmaceutical foam composition comprising betamethasone |
Family Cites Families (41)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4610978A (en) * | 1983-03-22 | 1986-09-09 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same |
| US4594340A (en) * | 1984-11-29 | 1986-06-10 | Hoffmann-La Roche Inc. | 25,26-dehydro-1α,24R-dihydroxycholecalciferol and 25,26-dehydro-1α,24S-dihydroxycholecalciferol and the epimeric mixture |
| WO1987000834A1 (en) * | 1985-08-02 | 1987-02-12 | Leo Pharmaceutical Products Ltd. A/S | Novel vitamin d analogues |
| US5401731A (en) * | 1989-06-29 | 1995-03-28 | Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Productionsaktieselskab) | Vitamin D analogues |
| US5824313A (en) * | 1989-09-25 | 1998-10-20 | University Of Utah Research Foundation | Vaccine compositions and method for induction of mucosal immune response via systemic vaccination |
| DE3933034A1 (de) * | 1989-10-02 | 1991-04-11 | Schering Ag | 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung |
| GB9004544D0 (en) * | 1990-03-01 | 1990-04-25 | Leo Pharm Prod Ltd | Novel treatment ii |
| GB9017890D0 (en) * | 1990-08-15 | 1990-09-26 | Leo Pharm Prod Ltd | Chemical compounds i |
| US5789397A (en) * | 1991-01-08 | 1998-08-04 | Bone Care International, Inc. | Methods for preparation and use of 1A,24(S)-dihydroxy vitamin D2 |
| IL99368A (en) * | 1991-09-02 | 1996-01-19 | Teva Pharma | Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine |
| GB9226860D0 (en) * | 1992-12-23 | 1993-02-17 | Leo Pharm Prod Ltd | Novel treatment |
| USRE39706E1 (en) * | 1993-01-15 | 2007-06-26 | Leo Pharma A/S | Crystalline form of a vitamin D analogue |
| US6103709A (en) * | 1993-12-23 | 2000-08-15 | The Regents Of The University Of California | Therapeutically effective 1α,25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases |
| NZ307549A (en) * | 1995-06-14 | 1999-11-29 | Schering Ag | Novel vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| WO1997013518A1 (en) * | 1995-10-10 | 1997-04-17 | Marilyn Strube | Treatment of pruritus with vitamin d and analogs thereof |
| DE69626539T2 (de) * | 1995-11-20 | 2004-04-08 | Kita, Kiyoshi, Shibuyaku | topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen |
| GB9524812D0 (en) * | 1995-12-05 | 1996-02-07 | Leo Pharm Prod Ltd | Chemical compounds |
| GB9611603D0 (en) * | 1996-06-04 | 1996-08-07 | Leo Pharm Prod Ltd | Chemical compounds |
| TWI247001B (en) * | 1996-07-01 | 2006-01-11 | Chugai Pharmaceutical Co Ltd | The method for purifying vitamin d derivatives and its crystalline products |
| GB9622590D0 (en) * | 1996-10-30 | 1997-01-08 | Leo Pharm Prod Ltd | Chemical compounds |
| US6017908A (en) * | 1997-05-16 | 2000-01-25 | Women And Infants Hospital | 3-EPI vitamin D2 compounds and uses thereof |
| US6599513B2 (en) * | 1997-05-27 | 2003-07-29 | Sembiosys Genetics Inc. | Products for topical applications comprising oil bodies |
| US6372234B1 (en) * | 1997-05-27 | 2002-04-16 | Sembiosys Genetics Inc. | Products for topical applications comprising oil bodies |
| US6187331B1 (en) * | 1997-06-10 | 2001-02-13 | New Vision Co., Ltd. | Composition for prophylaxis and/or treatment of dry syndrome comprising vitamin D |
| GB9721156D0 (en) * | 1997-10-06 | 1997-12-03 | Leo Pharm Prod Ltd | Novel vitamin d analogues |
| US6531459B1 (en) * | 1997-12-17 | 2003-03-11 | Schering Aktiengesellschaft | Vitamin D derivatives with phosphorus atoms in the side chains |
| US6231875B1 (en) * | 1998-03-31 | 2001-05-15 | Johnson & Johnson Consumer Companies, Inc. | Acidified composition for topical treatment of nail and skin conditions |
| JP2000064450A (ja) * | 1998-08-21 | 2000-02-29 | Kikkona Kk | 断熱性に優れたパネル材および断熱性に優れたパネル構造体 |
| CN1173703C (zh) * | 1999-04-23 | 2004-11-03 | 里奥药物制品有限公司 | 药物组合物 |
| DE19935771A1 (de) * | 1999-07-23 | 2001-02-01 | Schering Ag | Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln |
| WO2002034235A1 (en) * | 2000-10-27 | 2002-05-02 | Leo Pharma A/S | Topical composition containing at least one vitamin d or one vitamin d analogue and at least one corticosteroid |
| WO2003087048A2 (en) * | 2002-04-11 | 2003-10-23 | Instytut Farmaceutyczny | Preparation of 24 alkyl analogs of cholecalciferol and non-racemic compounds |
| JP4795023B2 (ja) * | 2004-02-03 | 2011-10-19 | 中外製薬株式会社 | ビタミンｄ化合物及びそれらの合成中間体の合成方法 |
| CA2567684A1 (en) * | 2004-06-17 | 2005-12-29 | Galderma S.A. | Composition in the form of a spray comprising a combination of clobetasol propionate and calcitriol, an alcohol phase and an oily phase |
| FR2871699A1 (fr) * | 2004-06-17 | 2005-12-23 | Galderma Sa | Composition de type emulsion inverse contenant du calcitrol et du 17-propionate de clobetasol, et ses utilisations en cosmetiques et en dermatologie |
| FR2871696B1 (fr) * | 2004-06-17 | 2006-11-10 | Galderma Sa | Composition topique pour le traitement du psoriasis |
| FR2871700B1 (fr) * | 2004-06-17 | 2006-11-17 | Galderma Sa | Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse |
| FR2871694B1 (fr) * | 2004-06-17 | 2008-07-04 | Galderma Sa | Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises |
| MXPA06014397A (es) * | 2004-06-17 | 2007-02-15 | Galderma Sa | Composicion en forma de aerosol que comprende una combinacion de un corticoide y un derivado de la vitamina d en una fase aceitosa. |
| FR2871697B1 (fr) * | 2004-06-17 | 2007-06-29 | Galderma Sa | Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, au moins un silicone volatile et une phase huileuse non volatile |
| WO2008065514A2 (en) * | 2006-11-29 | 2008-06-05 | Glenmark Pharmaceuticals Limited | Pharmaceutical compositions containing anhydrous calcipotriene |
-
2007
- 2007-08-29 BR BRPI0715636-7A patent/BRPI0715636A2/pt not_active IP Right Cessation
- 2007-08-29 US US11/897,540 patent/US20080064669A1/en not_active Abandoned
- 2007-08-29 EP EP07811641A patent/EP2056791A2/en not_active Withdrawn
- 2007-08-29 CA CA002670425A patent/CA2670425A1/en not_active Abandoned
- 2007-08-29 MX MX2009002337A patent/MX2009002337A/es unknown
- 2007-08-29 JP JP2009526737A patent/JP2010502624A/ja active Pending
- 2007-08-29 KR KR1020117022443A patent/KR20110113664A/ko not_active Ceased
- 2007-08-29 RU RU2009109164/15A patent/RU2452488C2/ru not_active IP Right Cessation
- 2007-08-29 WO PCT/US2007/019164 patent/WO2008027532A2/en not_active Ceased
- 2007-08-29 CN CNA2007800316568A patent/CN101505725A/zh active Pending
- 2007-08-29 KR KR1020097004890A patent/KR20090039833A/ko not_active Ceased
-
2009
- 2009-02-18 IL IL197107A patent/IL197107A0/en unknown
- 2009-03-27 NO NO20091297A patent/NO20091297L/no not_active Application Discontinuation
-
2011
- 2011-10-12 US US13/271,890 patent/US20120028934A1/en not_active Abandoned
- 2011-10-27 US US13/283,071 patent/US20120046253A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010502624A (ja) | 2010-01-28 |
| WO2008027532A3 (en) | 2008-04-17 |
| RU2452488C2 (ru) | 2012-06-10 |
| BRPI0715636A2 (pt) | 2013-07-02 |
| US20080064669A1 (en) | 2008-03-13 |
| MX2009002337A (es) | 2009-03-20 |
| CA2670425A1 (en) | 2008-03-06 |
| EP2056791A2 (en) | 2009-05-13 |
| KR20090039833A (ko) | 2009-04-22 |
| US20120046253A1 (en) | 2012-02-23 |
| WO2008027532A2 (en) | 2008-03-06 |
| IL197107A0 (en) | 2009-11-18 |
| US20120028934A1 (en) | 2012-02-02 |
| KR20110113664A (ko) | 2011-10-17 |
| CN101505725A (zh) | 2009-08-12 |
| RU2009109164A (ru) | 2010-10-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008027532A3 (en) | Pharmaceutical compositions including vitamin d and corticosteroid | |
| NO20073959L (no) | Kinazolinderivat, fremgangsmate for fremstilling og anvendelse derav for inhibering av vekst av kreftceller | |
| DK1494692T3 (da) | Topiske, farmaceutiske sammensætninger, der omfatter proanthocyanidiner, glycyrrhetinsyre og telmestein til behandlingen af dermatitis | |
| NO20092723L (no) | Indazolylester og amidderivater for behandling av gluccocorticoid reseptormedierte sykdommer | |
| WO2010093727A8 (en) | Quinazolinones as prolyl hydroxylase inhibitors | |
| NO20071617L (no) | Indozolonderivater som 11B-HSD1-inhibitorer | |
| WO2008061226A3 (en) | Sustained-release formulations of topiramate | |
| NO20082730L (no) | Morfolinopyrimidinderivater og deres anvendelse i terapi | |
| NO20080408L (no) | Azaindazolforbindelser og anvendelse derav | |
| WO2005075425A3 (en) | Substituted bisarylurea derivatives as kinase inhibitors | |
| WO2007135527A3 (en) | Benzimidazolyl compounds | |
| BRPI0513184A (pt) | derivados de 2-carbamida-4-feniltiazol, preparação dos mesmos e aplicação dos mesmos em terapia | |
| AR047928A1 (es) | Derivados de tetrahidropiridoindol | |
| PL1940249T3 (pl) | Nowe formulacje rozpuszczalnych w tłuszczach składników aktywnych o wysokiej biodostępności | |
| DE60206911D1 (de) | Imidazol-2-carbonsäureamid derivate als raf-kinase-inhibitoren | |
| NO20090346L (no) | Pyrazolderivater som inhibitorer av cytokrom P450 | |
| PA8566601A1 (es) | Derivados de nicotinamida utiles como inhibidores de pde4 | |
| MX2014005075A (es) | Formulaciones de sal de meglumina del acido 1-(5,6-dicloro-1h-benz o[d]imidazol-2-il)-1h-pirazol-4-carboxilico. | |
| MX376743B (es) | Síntesis de lactonas de ácido resorcílico útiles como agentes terapéuticos | |
| WO2008012338A3 (en) | Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions | |
| CY1111574T1 (el) | Παραγωγα βουτανοϊκου οξεος, διαδικασιες για την παρασκευη τους, φαρμακευτικες συνθεσεις που τα περιλαμβανουν και θεραπευτικες εφαρμογες αυτων | |
| HRP20041048B1 (hr) | POLIMORF 4-[2-[4-[1-(2-ETOKSIETIL)-1H-BENZIMIDAZOL-2-IL]-1-PIPERIDINIL]ETIL]-α, α- DIMETIL- BENZENOCTENE KISELINE | |
| WO2006083780A3 (en) | Glucuronidated nebivolol | |
| BRPI0517792A (pt) | macrolonas - quinolonas amino-substituìdas | |
| BRPI0407968A (pt) | derivados de oxamida úteis como inibidores de raf-quinase |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |